These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

870 related items for PubMed ID: 25848966

  • 1. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
    Kooistra AJ, Leurs R, de Esch IJ, de Graaf C.
    J Chem Inf Model; 2015 May 26; 55(5):1045-61. PubMed ID: 25848966
    [Abstract] [Full Text] [Related]

  • 2. The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.
    Warne T, Moukhametzianov R, Baker JG, Nehmé R, Edwards PC, Leslie AG, Schertler GF, Tate CG.
    Nature; 2011 Jan 13; 469(7329):241-4. PubMed ID: 21228877
    [Abstract] [Full Text] [Related]

  • 3. Function-specific virtual screening for GPCR ligands using a combined scoring method.
    Kooistra AJ, Vischer HF, McNaught-Flores D, Leurs R, de Esch IJ, de Graaf C.
    Sci Rep; 2016 Jun 24; 6():28288. PubMed ID: 27339552
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Stimulation of β1- and β2-adrenoceptors dilates retinal blood vessels in rats.
    Mori A, Sekito A, Sakamoto K, Ishii K, Nakahara T.
    Naunyn Schmiedebergs Arch Pharmacol; 2017 May 24; 390(5):527-533. PubMed ID: 28160015
    [Abstract] [Full Text] [Related]

  • 7. Ligand-binding affinity of alternative conformers of human β2 -adrenergic receptor in the presence of intracellular loop 3 (ICL3) and their potential use in virtual screening studies.
    Dilcan G, Doruker P, Akten ED.
    Chem Biol Drug Des; 2019 May 24; 93(5):883-899. PubMed ID: 30637937
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative Docking to Distinct G Protein-Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy.
    Scharf MM, Bünemann M, Baker JG, Kolb P.
    Mol Pharmacol; 2019 Dec 24; 96(6):851-861. PubMed ID: 31624135
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor.
    de Graaf C, Rognan D.
    J Med Chem; 2008 Aug 28; 51(16):4978-85. PubMed ID: 18680279
    [Abstract] [Full Text] [Related]

  • 14. Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor.
    Weiss DR, Ahn S, Sassano MF, Kleist A, Zhu X, Strachan R, Roth BL, Lefkowitz RJ, Shoichet BK.
    ACS Chem Biol; 2013 May 17; 8(5):1018-26. PubMed ID: 23485065
    [Abstract] [Full Text] [Related]

  • 15. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.
    DeVree BT, Mahoney JP, Vélez-Ruiz GA, Rasmussen SG, Kuszak AJ, Edwald E, Fung JJ, Manglik A, Masureel M, Du Y, Matt RA, Pardon E, Steyaert J, Kobilka BK, Sunahara RK.
    Nature; 2016 Jul 07; 535(7610):182-6. PubMed ID: 27362234
    [Abstract] [Full Text] [Related]

  • 16. Adenosine A1 receptors heterodimerize with β1- and β2-adrenergic receptors creating novel receptor complexes with altered G protein coupling and signaling.
    Chandrasekera PC, Wan TC, Gizewski ET, Auchampach JA, Lasley RD.
    Cell Signal; 2013 Apr 07; 25(4):736-42. PubMed ID: 23291003
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.